News & Updates

A red magnifying glass.

Losing weight lowers risk of hypertensive disorders of pregnancy

Losing weight lowers risk of hypertensive disorders of pregnancy

Lifestyle interventions or bariatric surgery leading to preconceptional weight loss effectively reduces the risk of hypertensive disorders of pregnancy (HDP), such as pregnancy-induced hypertension (PIH) and pre-eclampsia (PE), reports a recent meta-analysis.

Losing weight lowers risk of hypertensive disorders of pregnancy

14 Dec 2021

LNG-IUD may have systemic effects

LNG-IUD may have systemic effects

A small study presented at RSNA 2021 has suggested that the use of levonorgestrel-releasing intrauterine contraceptive devices (LNG-IUDs) may affect background parenchymal enhancement (BPE).

LNG-IUD may have systemic effects

Is ART safe for women with ulcerative colitis, Crohn's Disease?

Is ART safe for women with ulcerative colitis, Crohn's Disease?

Assisted reproductive technology (ART) is both safe and effective in women with ulcerative colitis and medically managed Crohn’s disease (CD), with comparable pregnancy and live birth rates to those of the general population, a study has shown.

Is ART safe for women with ulcerative colitis, Crohn's Disease?

Thicker subcutaneous fat during pregnancy ups pre-eclampsia risk

Thicker subcutaneous fat during pregnancy ups pre-eclampsia risk

Higher subcutaneous adipose tissue thickness during the second trimester, measured using ultrasound, appears to increase the risk of pre-eclampsia, a recent study has found.

Thicker subcutaneous fat during pregnancy ups pre-eclampsia risk

Original New Drug Application Approvals by US FDA (16 - 30 November 2021)

Original New Drug Application Approvals by US FDA (16 - 30 November 2021)

New drug applications approved by US FDA as of 16-30 November 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 30 November 2021)

Interpregnancy weight gain ups HDP risk

Interpregnancy weight gain ups HDP risk

Weight gain in between pregnancies worsens the risk hypertensive disorders of pregnancy (HDP), a recent study has found.

Interpregnancy weight gain ups HDP risk

05 Dec 2021

Caesarean delivery may reduce neonatal iron stores at birth

Caesarean delivery may reduce neonatal iron stores at birth

Caesarean delivery appears to obstruct placental transfusion from mother to neonate and lessens iron stores at birth, a recent study suggests.

Caesarean delivery may reduce neonatal iron stores at birth

Vaginal panel assay helps vaginitis patients get accurate diagnosis

Vaginal panel assay helps vaginitis patients get accurate diagnosis

An assay that detects DNA associated with bacterial vaginosis, vulvovaginal candidiasis, and Trichomonas vaginalis helps women get an accurate diagnosis, which in turn facilitates appropriate and timely treatment, according to a study.

Vaginal panel assay helps vaginitis patients get accurate diagnosis

04 Dec 2021

Folate supplementation helps increase ovarian reserve

Folate supplementation helps increase ovarian reserve

Higher intake of folate, specifically from supplements, results in a modest increase in ovarian reserve among women, as shown in a study.

Folate supplementation helps increase ovarian reserve

Metabolic dysfunction-associated fatty liver disease may harm pregnancy

Metabolic dysfunction-associated fatty liver disease may harm pregnancy

Metabolic dysfunction-associated fatty liver disease contributes to an increased risk of subsequent unfavourable pregnancy outcomes, a study reports.

Metabolic dysfunction-associated fatty liver disease may harm pregnancy

Something went wrong.